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ABSTRACT 
 
 
CLASSIFICATION TREE MODELS FOR PREDICTING CANCER STATUS 
 
 
 
 
 
 
 
 
 
By 
 
Pu Chen 
 
August 2009 
 
 
 
Thesis Supervised by Dr. Doug Landsittel 
 
 Early detection of cancers might improve the clinical outcomes. Multiple 
biomarkers with a novel LabMAP technology were used as the laboratory method to 
develop the diagnostic assay for ovarian, breast, endometrial, and lung cancer. To 
evaluate the accuracy of early stage detection, logistic regression (with forward selection) 
and classification tree models were applied as statistical methods. Furthermore, 
complexity parameters and the number of bootstrap samples were varied to assess the 
effect on sensitivity and specificity. The receiver operating characteristic curves reflected 
high sensitivities and specificities. 
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1. Introduction 
The early detection of cancer, i.e. finding tumors before the patient is symptomatic, 
is crucial for its ultimate control and prevention. For such efforts, effective treatment 
directly depends on disease stage, as the overall survival rates decrease drastically with 
the spread of metastatic disease. To prevent such disease progression and to identify 
localized cancer in asymptomatic patients, physicians rely on effective screening tests. 
However, to be utilized in a population setting, any such screening test must satisfy 
rigorous statistical requirements, such as extremely high sensitivity and specificity to 
early stage disease.[1] To accomplish such goals, the field of cancer research has recently 
focused more heavily on panels or arrays of biomarkers, which then require sophisticated 
statistical prediction models. More specifically, this thesis focuses on statistical issues in 
the application of one such method, classification trees, to a recently developed screening 
test (the Luminex panel of cytokines and other biomarkers).[1] 
Recently, much interest has been generated in studying biomarkers of cancer risk 
to predict future patterns of disease. Such efforts would then complement ongoing studies 
of cancer treatment, which have made substantially positive strides in the last few years. 
Serum biomarkers are produced by body organs or tumors and measure antigens on cell 
surfaces. When detected in high amounts in the blood, they can be suggestive of tumor 
activity. Cancer antigen 125 (CA-125) can be a biomarker of ovarian cancer risk. CA 15-
3 and 27-29 are biomarkers of breast cancer. Carcinoembryonic antigen (CEA) is another 
biomarker that is elevated in patients with colorectal, breast, lung, or pancreatic cancer. 
Maintaining high specificity (low false-positive rates) is a very high priority for 
population screening. Even a small false-positive rate translates into a large number of 
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people subjected to unnecessary costly diagnostic procedures. Thus, biomarkers need to 
be highly specific for cancer, and the use of several such biomarkers of cancer will likely 
be necessary for an overall screening program that is both sensitive and specific. 
However, in practice, many utilized biomarkers have insufficient sensitivity and/or 
specificity; others are too costly to use for screening purposes. 
For this study, methods will be illustrated for examples of ovarian cancer, breast 
cancer, endometrial cancer and lung cancer. Ovarian cancer is the third most frequent 
cancer of the female genital tract.[5] Annually, there are 23,000 women who are 
diagnosed with this disease and almost 14,000 women die from it.[7] However, because 
the majority of early stage ovarian cancers are asymptomatic, over 75% of clinical 
diagnoses are made at a time when the disease has already been regional or distant 
metastases.[5] With early stage detection, stage I disease has a cure rate of over 90%. On 
the other hand, for advanced ovarian cancer, the 5-year survival is only 15% to 20%.[5]  
Since early stage detection is very important for ovarian cancer, scientists have 
made great effort in this regard. The most popular screening tests for ovarian cancer are 
currently serologic screening for tumor antigen using cancer antigen-125 (CA-125) and 
imaging using transvaginal sonography.[5] However, none of the current serum markers, 
such as CA-125, can be used individually for screening.[9] For instance, with a cut-off of 
30 to 35 units/ml, serum CA-125 has been shown to have a sensitivity of only 50% to 
60% with the specificity of over 98%, for early-stage disease.[5] There is also the 
disadvantage of transvaginal sonography which is only sensitive and specific for 
established tumors, and is, therefore, not suitable for early diagnostics of ovarian 
cancer.[5] 
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Our second outcome of interest is breast cancer, which is the second leading cause 
of death from cancer in US women.[2,10] As a progressive disease, breast cancers have a 
better chance to be treated if found at the early stage.[2] Fortunately, the most popular 
breast cancer screening method (of mammography)  does, in many respects, provide an 
effective approach for early detection.[2] 
However, compared to the benefits of reduced morbidity and mortality, the 
screening has its limitations and can be harmful. On one hand, the majority of women 
who participate in screening will not develop breast cancer in their lifetime. On the other 
hand, screening will not benefit all women who are diagnosed with breast cancer. 
Furthermore, screening may be harmful to women who undergo biopsies for 
abnormalities that are not breast cancer, as well as those who are overtreated for ductal 
carcinoma in situ (DCIS) that might have been non-progressive. [2] 
Endometrial cancer is also studied in this article. From the recent research report, 
endometrial cancer is the fourth most common cancer in women in the United States, 
with more than 36,000 cases and 6,300 deaths occurring annually.[4] Although 
endometrial cancer is uncommon before age 40, there is an increasing trend with 
increasing age, peaking between ages 75 and 79.[6] With early stage detection of 
endometrial cancer while it is still localized, the five-year survival rate is 96%, compared 
with 44% for disease with distant metastasis. [6]  
However, there is no sufficient evidence to recommend screening women at 
average risk, or increased risk, due to history of unopposed estrogen therapy, tamoxifen 
therapy, late menopause, infertility or failure to ovulate, diabetes, or hypertension.[2,6] 
Although it is uncomfortable and often yields an inaccurate diagnosis, particularly for 
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women with endometrial polyps, the endometrial biopsy is still the most common 
technique to obtain endometrial tissue and the standard to determine the status of the 
endometrium.[3,4] 
The last but most deadly disease studied here is lung cancer, which is responsible 
for 1.3 million deaths worldwide annually. Nowadays the popular method to detect early 
stage lung cancer is the chest x-ray and spiral computed tomography (CT).[6] The data 
shows that patients who have significant exposure to tobacco smoke or occupational 
exposures are at high risk of lung cancer and may decide to undergo testing for early lung 
cancer detection on an individual basis after consultation with their physicians.[3] 
The circumstances leading to individual decisions about whether or not to undergo 
testing are more challenging today. There is growing evidence to indicate a possible 
benefit from testing for early stage lung cancer detection with the spiral CT. [11] There is 
also increased discussion of the potential benefits associated with early detection due to 
the media coverage of lung cancer diagnoses in well-known individuals.[3] 
As discussed above, cancer is a diverse disease, and it is unlikely that a single 
biomarker will detect all cancers of a particular organ with high sensitivity and specificity. 
In order to improve the accuracy of early stage detection, a combination of several tumor 
markers can give better risk predictions. Recently, studies have shown the role of 
cytokines as a new group of tumor markers.[12] A panel comprised of multiple cytokines 
might provide higher diagnostic power. This thesis evaluates the diagnostic utility of a 
cytokine panel that uses a novel multianalyte LabMAP profiling technology. This 
technique allows for simultaneous measurement of multiple markers using a Luminex 
platform.[12] 
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The primary method utilized in of this thesis is the classification tree approach. 
Classification trees are one of main techniques used in Data Mining, the discovery of 
interesting, unexpected or valuable structures in large data sets.[13] Data mining methods 
may be categorized as either the supervised or unsupervised. In unsupervised methods, no 
specific outcome variable is identified; all variables are treated in the same way as there 
is no distinction between predictor and response variables.[13] The most common 
unsupervised data mining method is clustering. 
Most Data Mining approaches are classified as supervised methods. The primary 
objective of such an analysis is usually to specify a relationship between predictor 
variables and response, as is done in linear regression. To apply supervised data mining 
techniques, the values of response variables must be known for all observations in the 
(training) data set. Some specific algorithm or set of calculations (such as maximum 
likelihood for instance) is then used to formulate the optimal model based on these data. 
One increasing common supervised data mining approach is the classification tree model. 
For this thesis, the primary focus is on evaluating variations of classification trees. The 
term classification tree implies that we are predicting categorical response variables. 
More generally, it can be applied to a variety of classification problems. Classification 
trees are widely used in applied fields as diverse as medicine (diagnosis), psychology 
(decision theory), computer science (data structures), and botany (classification). 
Furthermore, classification trees lend themselves to being displayed graphically, which 
makes them easier to interpret for individuals without a comprehensive knowledge of 
statistics. 
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2. Methodology 
2.1. Data Collection 
For this thesis, there are four types of cancer, ovarian cancer (n = 168 early stage 
and n = 105 late stage), breast cancer (n = 219), endometrial cancer (n = 167), and lung 
cancer (n = 74), with 322 normal controls. For each type, there are 28 variables: IL-2R 
(interleukin 2R), MMP-2, MMP-3, Cytokera, CA-153 (cancer antigen 153), ErbB2, 
Fas,sFa, EGFR, CA-125, CA19-9, CEA (carcinoembryonic antigen), CA72-4, AFP, 
Kallikre, Mesothel, sV-CAM, sI-CAM, MPO, tPAI 1, MIF, FSH, LH, TSH, PROLACTI, 
GH, ACTH, HE, sFasL. Cancer antigen 125 (CA-125) is a biomarker of ovarian cancer 
risk. CA 15-3 and 27-29 are biomarkers of breast cancer. Carcinoembryonic antigen 
(CEA) is another biomarker that is elevated in patients with breast, lung, or pancreatic 
cancer. CA-125 assay was further validated in comparison with standard clinical ELISA 
(Centocor, Malvern, PA) and has shown a correlation of 0.945. The 24-plex assay for IL-
1h, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL- 12p40, IL-13, IL-15, IL-17, IL-18, TNFa, 
IFNg, GM-CSF, EGF(epidermal growth factor), VEGF(vascular endothelial growth 
factor), G-CSF, basic fibroblast growth factor, hepatocyte growth factor (HGF), 
RANTES, macrophage inflammatory protein (MIP)-1a, MIP-1h, and MCP-1 was 
purchased from Biosource International. 
The Luminex (Austin, Tex.) Multi-Analyte Profiling (LabMAP) technology is 
based on microscopic polystyrene particles called microspheres that are internally labeled 
with two different fluorophores. When excited by a 635-nm laser, the fluorophore emits 
light at different wavelengths, 658 and 712 nm. By varying the 658-nm/712-nm emission 
ratios, an array of up to 100 different fluorescent profiles has been created. Using 
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precision fluidics, digital signal processors, and advanced optics, the unique Luminex 100 
analyzer classifies each microsphere according to its predefined fluorescent emission 
ratio. Thus, multiple microspheres coupled to different analytes can be combined in a 
single sample. A third fluorophore coupled to a reporter molecule allows for quantitation 
of the interaction that has occurred on the microsphere surface.[19] The ability of the 
Luminex system to simultaneously quantitate multiple analytes from a single sample 
source has proven to be a feasible and cost-effective technology for assay development. 
In this article, Luminex is a basic method to make the sensitivity and specificity closer to 
1. 
 
2.2. Statistical Models 
2.2.1. Logistic regression  
Logistic regression is a generalized linear model used for prediction of a 
probability of occurrence (of some event) by fitting data to a logistic curve. Consider the 
following model:  
           kk xxx ββββ ++++=⎟⎟⎠
⎞
⎜⎜⎝
⎛ Λ22110
i
i
y-1
ylog , 
where the response variable  is binary, i.e.  = 1 or 0, and the x-variables can follow 
any distribution. The goal of this model is to find the coefficients which yield predicted 
outcome values as close as possible to the observed values. Alternatively, we can 
consider the logistic function as follows: 
iy iy
       zezf −+= 1
1)(  
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where kk xxxz ββββ ++++= Λ22110 . Graphing this function yields the following (see 
Figure 1). 
 
Figure 1: The logistic function, with  on the horizontal axis and  on the vertical 
axis 
z )(zf
The coefficients, iβ , are typically estimated by the method of maximum likelihood. 
Essentially, the maximum likelihood method chooses as estimates those values of the 
parameters that are most consistent with the sample data. Denote  as a known 
probability density function (continuous distribution) or a known probability mass 
function (discrete distribution). For a sample of data set 
θf
kx,xx ,, 21 Λ , the probability 
function is . The likelihood function is as follows: ),( 1 kxxf Λθ ,, 2x
               ∏
=
=
n
i
kxxxfL
1
21 ),,,( Λθθ
The maximum likelihood estimator of θ, i.e. the vector of unknown parameters, is 
             . θθθ Lmaxargˆ =
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One objective of this thesis is to use logistic regression to model the probability of a 
patient being diagnosed with the given type of cancer, as a function of the serum 
biomarker variables. These results will then be used as a comparison to results with 
classification trees. 
 
2.2.2. Classification trees  
The primary focus of the study is the classification tree which is built through a 
process known as binary recursive partitioning. This is an iterative process of splitting the 
data into partitions, and then splitting it up further on each of branches. In this tree, leaves 
represent classifications and branches represent conjunctions of features that lead to those 
classifications. First, in the supervised methodology, the algorithm is provided with a 
training set of data (which is typically a random subset of the total data set). A temporary 
tree model is then constructed using the training samples provided in the training data set. 
However, the training set is necessarily incomplete; that is, it does not include the “new” 
or future data that the data modelers are really interested in classifying. Therefore, the 
algorithm needs to apply all patterns found in the training set to the future data, the so-
called test data. The next step of the supervised method is to examine how the provisional 
tree model performs on a test set of data. In the test set, the values of the target variable 
are hidden temporarily from the provisional model, which then performs the 
classification according to the patterns and structure it learned from the training set. The 
efficacy of the classifications is then evaluated by comparing them against the true values 
of the target variable.  
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For the training data set, tree construction usually comprises two steps: growing 
and pruning. The growing step begins with the root node, which is the entire learning 
sample. The most fundamental step in tree growing is to partition the root node into two 
subgroups, referred to as daughter nodes, such that one node contains mostly cancer 
tissue and the other node mostly normal tissue. A tissue is assigned to the right or left 
node according to whether the answer is yes or no. When all of tissues contained in the 
root are assigned to either the left or right nodes, the distribution in terms of the number 
of cancer tissues is assessed for both the left and right nodes using typically a node 
impurity. One function that can express this process is the following: 
             )1log()1()log( ttttt ppppi −−−−=    
where  is the proportion of cancer tissue in a specified node t. This function is at its 
lowest level when  = 0 or 
tp
tp . On the other hand, it reaches the maximum when  = tp 2
1 , 
that is, when the node is equally mixed with the cancer and normal tissues.  
The objective of the tree growing step is to produce a tree by executing the 
recursive partitioning process as far as possible. A natural concern is that such a saturated 
tree is generally too big and prone to noise. A second step is necessary to remove leaves 
and branches in order to improve the performance of the classification. The tree building 
algorithm makes the best split at the root where there are the largest number of records 
and, hence, a great deal of information. Each subsequent split has a smaller and less 
representative population with which to work. Towards the end, the character of training 
records at a particular node displays patterns that are specific only to those records. These 
patterns become meaningless and sometimes detrimental for prediction if one tries to 
 10
extend rules based on them to larger populations. The pruning procedure eliminates splits, 
beginning with the lowest branches, until a reasonable number of subtrees is specified. 
 
2.3. Model Specification and Assessment 
2.3.1. Model Selection 
Model selection is the task of selecting the optimal model from a set of possible 
models, based on some data set.[20] As part of this process, model selection includes 
determination of which predictor variables are significantly associated with the response 
variable.[20] For this thesis, logistic analyses will utilize forward selection, where 
independent variables are added to the model in order of importance, starting with no 
variables in the model; variables are added to the model, one at a time, until no other 
variables are statistically significant.[21,22] In contrast, classification trees automatically 
select the optimal variable set.  
To implement the forward selection approach (with logistic regression) we used the 
statistical programming package, R. R chooses the best model at each step using 
Akaike’s information criterion ( ). The  is an alternative criterion to the P-value 
and the F-test. It can essentially be viewed as the likelihood plus a penalty for adding 
predictors. More specifically, denote b  as the estimator of the parameter, 
AIC AIC
p  as the 
number of parameters in the model, where P  is the maximum number of possible 
parameters in the model, Pp ≤≤1 . This criterion is then given by: 
pbLAIC e 2)(log2 +−=  
where  is the log-likelihood expression, which is still from the method of 
maximum likelihood to estimate the parameter of the multiple logistic response function. 
)(log bLe
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More optimal models will yield relatively small values for this criterion. The first term 
 will never increase as terms is added to the model; the penalty  is then 
added to select the optimal model. The AIC criteria is asymptotically equivalent to using 
cross-validation. 
( )bLelog2−
maxTT ≤
p2
We describe the forward stepwise regression search algorithm as follows: 
1. The stepwise regression routine first fits a simple logistic regression model for 
each of the P potential predictor variables. Comparing the value of AIC  for 
each model, the predictor variable with the smallest AIC  value is the candidate 
for first addition. 
2. Assume 1X  is the variable entered at step 1. The stepwise routine fits all 
regression models with two predictor variables, where 1X  is one of the pair. For 
each such model, the AIC  value is calculated. The predictor variable which 
produces the smallest AIC  value is then added at the second step. 
3. Continue to add new predictor variables in the model until the AIC fails to 
decrease.  
For classification trees, the process of growing the tree is completely automated (as 
previously described). However, this process may lead to an overly complex tree.  This 
motivates the need to “prune” the tree. The idea behind pruning is this: For any subtree 
(from growing step), define its complexity as T ′ , the number of terminal nodes 
in T . Let 0≥α  be the complexity parameter and define the cost – complexity measure 
 as ( )TRα ( ) ( ) TTRT ′+= αRα . If one thinks of α  as the complexity cost per terminal 
node,  is formed by adding to the misclassification cost of the tree a cost penalty ( )TRα
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for complexity. For each value of α , find that subtree ( ) maxTT ≤α  which minimizes 
, i.e., ( )TRα ( )( ) ( )TRTR TT αα α maxmin≤= . 
Although α  runs through a continuum of values, there is at most a finite number of 
subtrees of . Thus, the pruning process produces a finite sequence of subtrees 
 with progressively fewer terminal nodes. Because of the finiteness, if 
maxT
Λ321 ,, TTT ( )αT  is 
the minimizing tree for a given value of α , then it continues to be minimizing as α  
increases until a jump point ( )α′Tα′  is reached, and a new tree  becomes the minimum 
tree until the next jump point α ′′ . For this thesis, the process is implemented with the 
prune function in R. 
 
2.3.2. Aggregate Predictors 
Bootstrapping is then used to calculate aggregate predictors. The term aggregate 
predictors refer to the process of fitting multiple models to each subject, and then 
specifying the average prediction from those models as the final predicted value. Doing 
so has shown to improve classification and generalization. The process of bootstrapping 
can be expressed as follows: Given a dataset, a bootstrap sample is created by forming B 
samples randomly selected with replacement; estimate the model from each bootstrap 
sample; estimate the predicted probability for each of the B models; finally, take the 
average of the B predictions as the final prediction.  Applying this process to 
classification models is then typically referred to as ‘bagging’. 
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2.3.3. Assessment of Classification Accuracy  
The probability of a true positive (sensitivity) and the probability of a true negative 
(specificity) are associated with threshold values. The sensitivity is the proportion of true 
positives that are correctly identified by the test. Meanwhile, the specificity is the 
proportion of true negatives that are correctly identified by the test. Denote the number of 
true positives by TP, true negatives by TN, false positives by FP, and false negatives by 
FN. The formulas for sensitivity, specificity and accuracy are  
sensitivity = TP / (TP + FN) 
specificity = TN / (TN + FP) 
accuracy = (TP + TN) / (P + N) 
In signal detection theory, the receiver operating characteristic curve (ROC) is a 
graphical plot of the sensitivity vs. (1 - specificity) as the discrimination threshold is 
varied across each of the observed predicted probabilities. The ROC curve plot is a 
popular way to display the discriminatory accuracy of a diagnostic test for detecting 
whether a patient has a cancer or not. A person has cancer (positive) or is healthy 
(negative) depending on whether the corresponding marker value is greater or less than a 
given threshold value.[14] The area under the ROC curve (AUC) is a measurement for 
the effectiveness of diagnostic markers.[14]  
Larger AUC values reflected better classification accuracy. Values of the AUC 
close to 1 mean that the marker has high accuracy.[15] More specifically, let x and y 
denote two randomly selected people with cancer and without cancer, respectively. The 
AUC turns out to be the probability that x will have a greater predicted probability than 
y.[15]  
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Using the same data set for both fitting models and assessing accuracy, in general, 
leads to biased prediction. Cross-validation is often used to reduce this bias. In K-fold 
cross-validation, the dataset is randomly split into K exclusive subsets (the folds) 
 of roughly equal size. For the  part, fit the model to the other K-1 parts, 
and calculate the misclassification rate of the fitted model when predicting the  part. 
Repeat this step for  then combine the K estimates of misclassification rate. 
Let  be the part which contains observation i . Denote 
KDDD ,,, 21 Λ
( )ik
thk
thk
Kk ,,2,1 Λ=
( )ik
iy
−ˆ  as the fitted value for 
observation i ,  is the real observation, and n is the number of observations. Hence, the 
cross-validation estimate of the misclassification rate is  
iy
                ( )( )2
1
ˆ1∑
=
−−=
n
i
ik
ii yyn
CV  
K is typically set to 10; we then refer to the process as 10-fold cross-validation. 
 
3. Results 
For the four types of cancer (ovarian, breast, endometrial and lung cancer), results 
are summarized for the misclassification rate, sensitivity and specificity across 200 
random partitions of the data. Hence, the following statistics are summaries of the 
classification estimates over all 200 random partitions. Plots of the ROC curve and area 
under the ROC curve (AUC) are also shown. Results for classification trees are 
summarized for each combination of the complexity parameter and number of bootstrap 
samples in bagging. 
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3. 1. Logistic Regression Analysis 
For each cancer type, the misclassification rate is typically small, with a minimum 
value of 0.068 (endometrial cancer), and a maximum value of 0.186 (breast cancer). The 
minimum sensitivity was 0.718 (lung cancer), with a maximum of 0.860 (endometrial 
cancer). For specificity, mean results varied between 0.859 (breast cancer) and 0.947 
(lung cancer). The maximum AUC was 0.988 (late stage ovarian cancer), with a 
minimum AUC of 0.925 (breast cancer). 
 
3. 1. 1. Logistic Regression Analysis of Early Stage Ovarian Cancer 
The mean misclassification rate was 0.107, with a mean sensitivity of 0.813, and a 
mean specificity of 0.935; see Table 1 for summaries of each classification measure. The 
AUC was 0.976. The whole result is shown in Table 1 and the ROC curve plot is in 
Figure 2. 
Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.106 (0.102) 0.082, 0.122 0.000, 0.245 
Sensitivity 0.813 (0.813) 0.750, 0.882 0.546, 1.000 
Specificity 0.935 (0.938) 0.909, 0.968 0.759, 1.000 
Table 1: Classification of early stage ovarian cancer using logistic analysis 
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Figure 2: The ROC curve of early stage ovarian cancer using logistic analysis 
 
3. 1. 2. Logistic Regression Analysis of Late Stage Ovarian Cancer 
The mean of misclassification rate is 0.071, with the mean sensitivity of 0.848, and 
a mean specificity of 0.956. The AUC is 0.988. The whole result is shown in Table 2 and 
the ROC curve is in Figure 3. 
Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.071 (0.070) 0.046, 0.093 0.000, 0.186 
Sensitivity 0.848 (0.857) 0.786, 0.917 0.500, 1.000 
Specificity 0.956 (0.967) 0.935, 0.972 0.833, 1.000 
Table 2: Classification of late stage ovarian cancer using logistic analysis 
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Figure 3: The ROC curve of late stage ovarian cancer using logistic analysis 
 
3. 1. 3. Logistic Regression Analysis of Breast Cancer 
The mean misclassification rate is 0.186, with a mean sensitivity of 0.753, and a 
mean specificity of 0.859. The AUC is 0.925. The whole result is shown in Table 3 and 
the ROC curve plot is in Figure 4. 
Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.186 (0.185) 0.148, 0.222 0.056, 0.389 
Sensitivity 0.753 (0.750) 0.700, 0.818 0.526, 1.000 
Specificity 0.859 (0.864) 0.818, 0.906 0.634, 1.000 
Table 3: Classification of breast cancer using logistic analysis 
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Figure 4: The ROC curve of breast cancer using logistic analysis 
 
3. 1. 4. Logistic Regression Analysis of Endometrial Cancer 
In this case, the data set of endometrial cancer1 and endometrial cancer2 is 
combined. The mean of the misclassification rate is 0.094, with a mean sensitivity of 
0.860, and a mean specificity of 0.930. The AUC is 0.981. The whole result is shown in 
Table 4 and the ROC curve is in Figure 5. 
Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.094 (0.082) 0.061, 0.122 0.000, 0.245 
Sensitivity 0.860 (0.867) 0.800, 0.929 0.611, 1.000 
Specificity 0.930 (0.934) 0.900, 0.967 0.813, 1.000 
Table 4: Classification of endometrial cancer using logistic analysis 
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Figure 5: The ROC curve of endometrial cancer using logistic analysis 
 
3. 1. 5. Logistic Regression Analysis of Lung Cancer 
The mean of misclassification rate is 0.097, with the mean sensitivity of 0.718, and 
0.947 for specificity. The AUC is 0.971. The whole result is shown in Table 5 and the 
ROC curve is in Figure 6. 
Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.097 (0.100) 0.075, 0.125 0.025, 0.250 
Sensitivity 0.718 (0.714) 0.619, 0.814 0.250, 1.000 
Specificity 0.947 (0.952) 0.931, 0.971 0.800, 1.000 
Table 5: Classification of lung cancer using logistic analysis 
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Figure 6: The ROC curve of lung cancer using logistic analysis 
 
3. 2. Classification Tree Analysis without Pruning or Bagging 
For each type of cancer, the misclassification rate is small, with a minimum value 
of 0.068 (endometrial cancer), and a maximum value of 0.231 (breast cancer). The 
minimum sensitivity is 0.636 (lung cancer), with a maximum of 0.908 (endometrial 
cancer). For specificity, mean results varied between 0.808 (breast cancer) and 0.962 (late 
stage ovarian cancer). The minimum AUC is 0.886 (breast cancer), with a maximum 
AUC of 0.991 (endometrial cancer). 
 
3. 2. 1. Classification Tree Analysis of Early Stage Ovarian Cancer 
The mean of the misclassification rate is 0.124, with the mean sensitivity of 0.799, 
and 0.916 for specificity. The AUC is 0.967. The whole result is shown in Table 6 and 
the ROC curve plot is in Figure 7. 
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 Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.124 (0.122) 0.082, 0.163 0.020, 0.245 
Sensitivity 0.799 (0.810) 0.730, 0.882 0.364, 1.000 
Specificity 0.916 (0.914) 0.878, 0.948 0.778, 1.000 
Table 6: Classification of early stage ovarian cancer using classification trees (without 
pruning or bagging) 
 
Figure 7: The ROC curve of early stage ovarian cancer using classification trees (without 
pruning or bagging) 
 
3. 2. 2. Classification Tree Analysis of Late Stage Ovarian Cancer 
The mean misclassification rate is 0.068, with the mean sensitivity of 0.840, and 
0.962 for specificity. The AUC is 0.990. The whole result is shown in Table 7 and the 
ROC curve is in Figure 8. 
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 Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.069 (0.070) 0.047, 0.093 0.000, 0.186 
Sensitivity 0.840 (0.846) 0.778, 0.917 0.375, 1.000 
Specificity 0.962 (0.969) 0.939, 1.000 0.800, 1.000 
Table 7: Classification of late stage ovarian cancer with classification trees (without 
pruning or bagging) 
 
Figure 8: The ROC curve of late stage ovarian cancer using classification trees (without 
pruning or bagging) 
 
3. 2. 3. Classification Tree Analysis of Breast Cancer 
The mean misclassification rate is 0.237, with the mean sensitivity of 0.705, and 
0.808 for specificity. The AUC is 0.885. The whole result is shown in Table 8 and the 
ROC curve is in Figure 9. 
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 Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.237 (0.232) 0.204, 0.278 0.130, 0.370 
Sensitivity 0.705 (0.706) 0.630, 0.778 0.444, 1.000 
Specificity 0.808 (0.814) 0.750, 0.867 0.576, 1.000 
Table 8: Classification of breast cancer using classification trees (without pruning or 
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4. Classification Tree Analysis of Endometrial Cancer 
The mean misclassification rate is 0.068, with the mean sensitivity of 0.908, and 
0.944 for specificity. The AU
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 Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.068 (0.061) 0.041, 0.082 0.000, 0.224 
Sensitivity 0.908 (0.926) 0.867, 0.955 0.632, 1.000 
Specificity 0.944 (0.944) 0.917, 0.971 0.811, 1.000 
Table 9: Classification of endometrial cancer using classification tree analysis (without 
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5. Classification Tree Analysis of Lung Cancer 
The mean misclassification rate is 0.108, with the mean sensitivity of 0.636, and 
0.953 for specificity. The AU
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 Index Mean (Median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.108 (0.100) 0.075, 0.150 0.000, 0.275 
Sensitivity 0.636 (0.667) 0.500, 0.757 0.167, 1.000 
Specificity 0.953 (0.967) 0.930, 1.000 0.781, 1.000 
Table 10: Classification of lung cancer using classification trees (without pruning or 
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Classification Tree Analysis with Pruning without Bagging 
Comparing the four types of cancers for the complexity parameters (cpar) 0.01, 
0.02 and 0.05, the minimum value of the misclassification rate is 0.055 (late stage ovar
cancer), and the maximum value is 0.266 (breast cancer). The minimum sensitivity is 
0.606 (breast cancer), with a maximum of 0.908 (endometrial cancer). For specificity, 
mean results varied between 0.808 (breast cancer) and 0.962 (lung cancer). The minimum 
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AUC is 0.835 (breast cancer), with a maximum AUC of 0.994 (late stage ovarian cancer)
For each type of cancer, specifying cpar=0.01 does not affect the result. The resul
change, however, for cpar=
. 
t does 
0.02 and cpar=0.05. Hence, results are not shown for 
cpar=0.01 in this section. 
3. 3. 
8 
he whole result is shown in Table 11 and the 
urve plot is a
lexity 
parameter 
) 
 
1. Classification Tree Analysis of Early Stage Ovarian Cancer 
The minimum mean of the misclassification rate is 0.120, with the maximum mean 
of 0.152. The minimum value of the sensitivity is 0.695, with a maximum value of 0.824. 
The specificity mean is between 0.914 and 0.930. The AUC is 0.967 for cpar=0.01, 0.96
for cpar=0.02, and 0.920 for cpar=0.05. T
ROC c in Figures 12 nd 13. 
Index Comp Mean(median Q1, Q3 Min, Max 
Misclassification 
ate R
0.01 0.124(0.122) 0.082,0.163 0.020,0.245 
 0.02 0.120(0.122) 0.082,0.148 0.000,0.245 
 0.05 0.152(0.143) 0.122,0.184 0.041,0.306 
Sensitivity 0.01 0.799 (0.810) 0.730, 0.882 0.364, 1.000 
 0.02 0.814 (0.824) 0.736, 0.895 0.455, 1.000 
 0.05 0.695 (0.690) 0.632, 0.779 0.333, 0.937 
Specificity 0.01 0.916 (0.914) 0.879, 0.948 0.778, 1.000 
 0.02 0.914 (0.912) 0.879, 0.958 0.769, 1.000 
 0.05 0.930 (0.941) 0.892, 0.969 0.714, 1.000 
Table 11: Classification of early stage ovarian cancer using classification trees with 
pruning and without bagging 
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Figure 12: The ROC curve plot of the early stage ovarian cancer using classification trees 
with pruning and complexity parameter 0.02 without bagging 
 
Figure 13: The ROC curve plot of the early stage ovarian cancer using classification trees 
with pruning and complexity parameter 0.05 without bagging 
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3. 3. 
. The whole result is shown in Table 12 and 
C curve plo  1
lexity 
eter 
) 
2. Classification Tree Analysis of Late Stage Ovarian Cancer 
The minimum mean of the misclassification rate is 0.120, with the maximum mean 
of 0.152. The minimum value of the sensitivity is 0.695, with a maximum value of 0.824. 
The specificity mean changes between 0.914 and 0.930. The AUC is 0.990 for cpar=0.01, 
0.992 for cpar=0.02, and 0.994 for cpar=0.05
the RO t is in Figures 4 and 15. 
Index Comp
param
Mean(median Q1, Q3 Min, Max 
Misclassification 
ate R
0.01 0.068 (0.070) 0.047,0.093 0.000,0.186 
 0.02 0.058 (0.047) 0.023,0.070 0.000,0.186 
 0.05 0.055 (0.047) 0.023,0.070 0.000,0.186 
Sensitivity 0.01 0.840 (0.846) 0.778, 0.917 0.375, 1.000 
 0.02 0.888 (0.900) 0.833, 1.000 0.600, 1.000 
 0.05 0.901 (0.909) 0.857, 1.000 0.600, 1.000 
Specificity 0.01 0.962 (0.969) 0.939, 1.000 0.800, 1.000 
 0.02 0.960 (0.968) 0.939, 1.000 0.800, 1.000 
 0.05 0.960 (0.968) 0.939, 1.000 0.800, 1.000 
Table 12: Classification of the late stage ovarian cancer using classification trees with 
 
pruning and without bagging 
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Figure 14: The ROC curve plot of the late stage ovarian cancer using classification trees 
with pruning and complexity parameter 0.02 without bagging 
 
Figure 15: The ROC curve plot of the late stage ovarian cancer using classification trees 
with pruning and complexity parameter 0.05 without bagging 
 
3. 3. 3. Classification Tree Analysis of Breast Cancer 
The minimum mean of the misclassification rate is 0.237, with the maximum mean 
of 0.266. The minimum sensitivity is 0.602, with a maximum value of 0.705. The 
specificity mean ranges between 0.808 and 0.832. The AUC is 0.885 for cpar=0.01, 0.882 
for cpar=0.02, and 0.840 for cpar=0.05. The whole result is shown in Table 13 and the 
ROC curve plot is in Figures 16 and 17. 
Index Complexity 
parameter 
Mean(median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.01 0.237 (0.232) 0.204, 0.278 0.130, 0.370 
 0.02 0.241 (0.241) 0.204, 0.278 0.093, 0.352 
 0.05 0.266 (0.259) 0.222, 0.296 0.148, 0.407 
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Table 13 continued 
Index Complexity 
parameter 
Mean(median) Q1, Q3 Min, Max 
Sensitivity 0.01 0.705 (0.706) 0.630, 0.778 0.444, 1.000 
 0.02 0.685 (0.690) 0.614, 0.762 0.444, 1.000 
 0.05 0.602 (0.600) 0.523, 0.679 0.318, 0.933 
Specificity 0.01 0.808 (0.814) 0.750, 0.867 0.576, 1.000 
 0.02 0.816 (0.817) 0.769, 0.871 0.621, 1.000 
 0.05 0.832 (0.836) 0.780, 0.889 0.618, 1.000 
Table 13: Classification of the breast cancer using classification trees with pruning and 
without bagging 
 
Figure 16: The ROC curve plot of the breast cancer using classification trees with 
pruning and complexity parameter 0.02 without bagging 
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Figure 17: The ROC curve plot of the breast cancer using classification trees with 
pruning and complexity parameter 0.05 without bagging 
 
3. 3. 4. Classification Tree Analysis of Endometrial Cancer 
The minimum mean of the misclassification rate is 0.066, with the maximum mean 
of 0.079. The minimum sensitivity is 0.903, with a maximum value of 0.908. The 
specificity mean ranges between 0.928 and 0.950. The AUC is 0.991 for cpar=0.01, 0.992 
for cpar=0.02, and 0.987 for cpar=0.05. The whole result is shown in Table 14 and the 
ROC curve plot is in Figures 18 and 19. 
Index Complexity 
parameter 
Mean(median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.01 0.068(0.061) 0.041, 0.082 0.000, 0.224 
 0.02 0.066(0.061) 0.041, 0.082 0.000, 0.224 
 0.05 0.079(0.082) 0.061, 0.102 0.000, 0.224 
Sensitivity 0.01 0.908 (0.926) 0.867, 0.955 0.632, 1.000 
 0.02 0.903 (0.915) 0.857, 0.950 0.632, 1.000 
 0.05 0.908 (0.923) 0.867, 0.950 0.632, 1.000 
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Table 14 continued 
Index Complexity 
parameter 
Mean(median) Q1, Q3 Min, Max 
Specificity 0.01 0.944 (0.944) 0.917, 0.971 0.811, 1.000 
 0.02 0.950 (0.962) 0.931, 0.971 0.807, 1.000 
 0.05 0.928 (0.931) 0.903, 0.967 0.807, 1.000 
Table 14: Classification of the endometrial cancer using classification trees with pruning 
and without bagging 
 
 
Figure 18: The ROC curve plot of the endometrial cancer using classification trees with 
pruning and complexity parameter 0.02 without bagging 
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Figure 19: The ROC curve plot of the endometrial cancer using classification trees with 
pruning and complexity parameter 0.05 without bagging 
 
3. 3. 5. Classification Tree Analysis of Lung Cancer 
The minimum mean of the misclassification rate is 0.103, with the maximum mean 
of 0.109. The minimum sensitivity is 0.622, with a maximum value of 0.636. The 
specificity mean ranges between 0.953 and 0.962. The AUC is 0.965 for cpar=0.01, 0.964 
for cpar=0.02, and 0.970 for cpar=0.05. The whole result is shown in Table 15 and the 
ROC curve plot is in Figures 20 and 21. 
Index Complexity 
parameter 
Mean(median) Q1, Q3 Min, Max 
Misclassification 
Rate 
0.01 0.108 (0.100) 0.075, 0.150 0.000, 0.275 
 0.02 0.109 (0.100) 0.075, 0.150 0.000, 0.225 
 0.05 0.103 (0.100) 0.075, 0.125 0.000, 0.225 
Sensitivity 0.01 0.636 (0.667) 0.500, 0.757 0.167, 1.000 
 0.02 0.622 (0.625) 0.500, 0.750 0.167, 1.000 
 0.05 0.626 (0.625) 0.500, 0.750 0.125, 1.000 
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Table 15 continued 
Index Complexity 
parameter 
Mean(median) Q1, Q3 Min, Max 
Specificity 0.01 0.953 (0.967) 0.930, 1.000 0.781, 1.000 
 0.02 0.955 (0.968) 0.933, 1.000 0.800, 1.000 
 0.05 0.962 (0.970) 0.939, 1.000 0.833, 1.000 
Table 15: Classification of the lung cancer using classification trees with pruning and 
without bagging 
 
 
Figure 20: The ROC curve plot of the lung cancer using classification trees with pruning 
and complexity parameter 0.02 without bagging 
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Figure 21: The ROC curve plot of the lung cancer with classification trees with pruning 
and complexity parameter 0.05 without bagging 
 
3. 4. Classification Tree Analysis with Bagging without Pruning 
Comparing the four types of cancers for different numbers of bootstrap samples in 
bagging, 5, 20, and 50, the minimum misclassification rate is 0.033 (late stage ovarian 
cancer), and the maximum value is 0.074 (breast cancer). The minimum sensitivity is 
0.770 (lung cancer), with a maximum of 0.940 (breast cancer). For specificity, the mean 
results varied between 0.951 (breast cancer) and 0.984 (lung cancer). The minimum AUC 
is 0.990 (breast cancer), with a maximum AUC of 0.999 (breast cancer).  
 
3. 4. 1. Classification Tree Analysis of Early Stage Ovarian Cancer 
The minimum mean of the misclassification rate is 0.046, with the maximum mean 
of 0.058. The minimum value of the sensitivity is 0.899, with a maximum value of 0.911. 
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The specificity mean ranges between 0.965 and 0.976. The AUC is from 0.994 to 0.996. 
The whole result is shown in Table 16 and the ROC curve plot is in Figures 22, 23 and 24. 
Index Bootstrap 
Samples 
Mean 
(median) 
Q1, Q3 Min, Max 
Misclassification 
Rate 
5 0.058 (0.061) 0.041, 0.082 0.000, 0.163 
 20 0.049 (0.041) 0.020, 0.061 0.000, 0.143 
 50 0.046 (0.041) 0.020, 0.061 0.000, 0.143 
Sensitivity 5 0.899 (0.909) 0.857, 0.941 0.643, 1.000 
 20 0.903 (0.917) 0.857, 0.947 0.667, 1.000 
 50 0.911 (0.926) 0.875, 0.947 0.722, 1.000 
Specificity 5 0.965 (0.969) 0.939, 1.000 0.849, 1.000 
 20 0.976 (0.973) 0.965, 1.000 0.875, 1.000 
 50 0.976 (0.973) 0.966, 1.000 0.875, 1.000 
Table 16: Classification of the early stage ovarian cancer using classification trees with 
bagging and without pruning 
 
Figure 22: The ROC curve plot of the early stage ovarian cancer using classification trees 
with 5 bootstrap samples in bagging and without pruning 
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Figure 23: The ROC curve plot of the early stage ovarian cancer using classification trees 
with 20 Bootstrap samples in bagging and without pruning 
 
Figure 24: The ROC curve plot of the early stage ovarian cancer using classification trees 
with 50 Bootstrap samples in bagging and without pruning 
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3. 4. 2. Classification Tree Analysis of Late Stage Ovarian Cancer 
The minimum mean of the misclassification rate is 0.033, with the maximum mean 
of 0.038. The minimum value of the sensitivity is 0.925, with a maximum value of 0.931. 
The specificity mean ranges between 0.975 and 0.980. The AUC is from 0.998 to 0.998. 
The whole result is shown in Table 17 and the ROC curve plot is in Figures 25, 26 and 27. 
Index Bootstrap 
Samples 
Mean 
(median) 
Q1, Q3 Min, Max 
Misclassification 
Rate 
5 0.038 (0.023) 0.023, 0.047 0.000, 0.140 
 20 0.033 (0.023) 0.023, 0.047 0.000, 0.116 
 50 0.034 (0.023) 0.023, 0.047 0.000, 0.140 
Sensitivity 5 0.925 (0.929) 0.875, 1.000 0.667, 1.000 
 20 0.929 (0.920) 0.881, 1.000 0.667, 1.000 
 50 0.931 (0.929) 0.889, 1.000 0.667, 1.000 
Specificity 5 0.975 (0.972) 0.967, 1.000 0.879, 1.000 
 20 0.980 (1.000) 0.968, 1.000 0.879, 1.000 
 50 0.978 (0.972) 0.968, 1.000 0.879, 1.000 
Table 17: Classification of the late stage ovarian cancer using classification trees with 
bagging and without pruning 
 
Figure 25: The ROC curve plot of the late stage ovarian cancer using classification trees 
with 5 Bootstrap samples in bagging and without pruning 
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Figure 26: The ROC curve plot of the late stage ovarian cancer using classification trees 
with 20 Bootstrap samples in bagging and without pruning 
 
Figure 27: The ROC curve plot of the late stage ovarian cancer using classification trees 
with 50 Bootstrap samples in bagging and without pruning 
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3. 4. 3. Classification Tree Analysis of Breast Cancer 
The minimum mean of the misclassification rate is 0.035, with the maximum mean 
of 0.074. The minimum value of the sensitivity is 0.890, with a maximum value of 0.940. 
The specificity mean ranges between 0.951 and 0.982. The AUC is from 0.990 to 0.999. 
The whole result is shown in Table 18 and the ROC curve plot is in Figures 28, 29 and 30. 
Index Bootstrap 
Samples 
Mean 
(median) 
Q1, Q3 Min, Max 
Misclassification 
Rate 
5 0.074 (0.074) 0.056, 0.093 0.000, 0.241 
 20 0.045 (0.037) 0.019, 0.056 0.000, 0.130 
 50 0.035 (0.037) 0.019, 0.056 0.000, 0.093 
Sensitivity 5 0.890 (0.900) 0.848, 0.950 0.696, 1.000 
 20 0.916 (0.920) 0.889, 0.953 0.750, 1.000 
 50 0.940 (0.952) 0.909, 0.969 0.773, 1.000 
Specificity 5 0.951 (0.964) 0.930, 0.974 0.806, 1.000 
 20 0.982 (1.000) 0.968, 1.000 0.895, 1.000 
 50 0.982 (1.000) 0.969, 1.000 0.897, 1.000 
Table 18: Classification of the breast cancer using classification trees with bagging and 
without pruning 
 
Figure 28: The ROC curve plot of the breast cancer using classification trees with 5 
Bootstrap samples in bagging and without pruning 
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Figure 29: The ROC curve plot of the breast cancer using classification trees with 20 
Bootstrap samples in bagging and without pruning 
 
Figure 30: The ROC curve plot of the breast cancer using classification trees with 50 
Bootstrap samples in bagging and without pruning 
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3. 4. 4. Classification Tree Analysis of Endometrial Cancer 
The minimum mean of the misclassification rate is 0.044, with the maximum mean 
of 0.049. The minimum value of the sensitivity is 0.927, with a maximum value of 0.929. 
The specificity mean ranges between 0.962 and 0.969. The AUC is from 0.996 to 0.997. 
The whole result is shown in Table 19 and the ROC curve plot is in Figures 31, 32 and 33. 
Index Bootstrap 
Samples 
Mean 
(median) 
Q1, Q3 Min, Max 
Misclassification 
Rate 
5 0.049 (0.041) 0.020, 0.061 0.000, 0.184 
 20 0.046 (0.041) 0.020, 0.061 0.000, 0.184 
 50 0.044 (0.041) 0.020, 0.061 0.000, 0.143 
Sensitivity 5 0.929 (0.941) 0.888, 1.000 0.688, 1.000 
 20 0.927 (0.941) 0.882, 1.000 0.706, 1.000 
 50 0.929 (0.941) 0.887, 1.000 0.714, 1.000 
Specificity 5 0.962 (0.968) 0.939, 1.000 0.839, 1.000 
 20 0.968 (0.970) 0.943, 1.000 0.871, 1.000 
 50 0.969 (0.971) 0.948, 1.000 0.871, 1.000 
Table 19: Classification of the endometrial cancer using classification trees with bagging 
and without pruning 
 
Figure 31: The ROC curve plot of the endometrial cancer using classification trees with 5 
Bootstrap samples in bagging and without pruning 
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Figure 32: The ROC curve plot of the endometrial cancer using classification trees with 
20 Bootstrap samples in bagging and without pruning 
 
Figure 33: The ROC curve plot of the endometrial cancer using classification trees with 
50 Bootstrap samples in bagging and without pruning 
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3. 4. 5. Classification Tree Analysis of Lung Cancer 
The minimum mean of the misclassification rate is 0.054, with the maximum mean 
of 0.062. The minimum value of the sensitivity is 0.770, with a maximum value of 0.788. 
The specificity mean ranges between 0.977 and 0.984. The AUC is from 0.991 to 0.995. 
The whole result is shown in Table 20 and the ROC curve plot is in Figures 34, 35 and 36. 
Index Bootstrap 
Samples 
Mean 
(median) 
Q1, Q3 Min, Max 
Misclassification 
Rate 
5 0.062 (0.050) 0.025, 0.075 0.000, 0.175 
 20 0.056 (0.050) 0.025, 0.075 0.000, 0.175 
 50 0.054 (0.050) 0.025, 0.075 0.000,0.175 
Sensitivity 5 0.770 (0.800) 0.656, 0.889 0.286, 1.000 
 20 0.774 (0.800) 0.667, 0.875 0.286, 1.000 
 50 0.788 (0.800) 0.714, 0.889 0.286, 1.000 
Specificity 5 0.977 (0.971) 0.968, 1.000 0.906, 1.000 
 20 0.984 (1.000) 0.970, 1.000 0.914, 1.000 
 50 0.984 (1.000) 0.970, 1.000 0.900, 1.000 
Table 20: Classification of the lung cancer using classification trees with bagging and 
without pruning 
 
Figure 34: The ROC curve plot of the lung cancer using classification trees with 5 
Bootstrap samples in bagging and without pruning 
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Figure 35: The ROC curve plot of the lung cancer using classification trees with 20 
Bootstrap samples in bagging and without pruning 
 
Figure 36: The ROC curve plot of the lung cancer using classification trees with 50 
Bootstrap samples in bagging and without pruning 
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3. 5. Classification Tree Analysis with Pruning and Bagging 
Combining the different number of bootstrap samples in bagging, 5, 20, and 50 and 
cpar=0.01, 0.02 and 0.05, the minimum misclassification rate is 0.033 (late stage ovarian 
cancer), and the maximum value is 0.164 (breast cancer). The minimum sensitivity is 
0.695 (lung cancer), with a maximum of 0.940 (breast cancer). For specificity, the mean 
results varied between 0.917 (breast cancer) and 0.985 (lung cancer). Note, for each type 
of cancer, cpar=0.01 does not affect the result. 
 
3. 5. 1. Classification Tree Analysis of Early Stage Ovarian Cancer 
The minimum mean misclassification rate is 0.046, with the maximum mean of 
0.152. The minimum value of the sensitivity is 0.825, with a maximum value of 0.911. 
The specificity mean varies between 0.957 and 0.974. The whole result is shown in Table 
21. 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Misclassification 
rate 
0.01 Mean 
(median) 
0.058 
(0.061) 
0.049 
(0.041) 
0.046 
(0.041) 
  Q1  
Q3 
0.041 
0.082 
0.020 
0.061 
0.020 
0.061 
  Min,  
Max 
0.000 
0.163 
0.000 
0.143 
0.000 
0.143 
Sensitivity  Mean 
(median) 
0.899 
(0.909) 
0.903 
(0.917) 
0.911 
(0.926) 
  Q1  
Q3 
0.857 
0.941 
0.857 
0.947 
0.875 
0.947 
  Min  
Max 
0.643 
1.000 
0.667 
1.000 
0.722 
1.000 
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Table 21 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.01 Mean 
(median) 
0.965 
(0.969) 
0.976 
(0.973) 
0.976 
(0.973) 
  Q1  
Q3 
0.939 
1.000 
0.965 
1.000 
0.966 
1.000 
  Min  
Max 
0.849 
1.000 
0.875 
1.000 
0.875 
1.000 
Misclassification 
rate 
0.02 Mean 
(median) 
0.062 
(0.061) 
0.056 
(0.061) 
0.053 
(0.041) 
  Q1  
Q3 
0.041 
0.082 
0.041 
0.082 
0.041 
0.061 
  Min  
Max 
0.000 
0.163 
0.000 
0.163 
0.000 
0.143 
Sensitivity  Mean 
(median) 
0.890 
(0.900) 
0.886 
(0.895) 
0.896 
(0.900) 
  Q1 
Q3 
0.845 
0.938 
0.833 
0.941 
0.857 
0.941 
  Min  
Max 
0.667 
1.000 
0.667 
1.000 
0.667  
1.000 
Specificity  Mean 
(median) 
0.962 
(0.968) 
0.974 
(0.971) 
0.974 
(0.973) 
  Q1  
Q3 
0.939 
1.000 
0.963 
1.000 
0.966 
1.000 
  Min  
Max 
0.849 
1.000 
0.875 
1.000 
0.867 
1.000 
Misclassification 
rate 
0.05 Mean 
(median) 
0.152 
(0.143) 
0.078 
(0.082) 
0.070 
(0.061) 
  Q1  
Q3 
0.061 
0.122 
0.061 
0.102 
0.041 
0.082 
  Min  
Max 
0.000 
0.224 
0.000 
0.184 
0.000 
0.163 
Sensitivity  Mean 
(median) 
0.825 
(0.838) 
0.830 
(0.842) 
0.852 
(0.857) 
  Q1  
Q3 
0.765 
0.905 
0.765 
0.900 
0.790 
0.923 
  Min  
Max 
0.400 
1.000 
0.533 
1.000 
0.600 
1.000 
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Table 21 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.05 Mean 
(median) 
0.957 
(0.969) 
0.970 
(0.970) 
0.971 
(0.970) 
  Q1  
Q3 
0.936 
1.000 
0.946 
1.000 
0.964 
1.000 
  Min  
Max 
0.778 
1.000 
0.880 
1.000 
0.867 
1.000 
Table 21: Classification of the early stage ovarian cancer using classification trees with 
pruning and bagging 
 
3. 5. 2. Classification Tree Analysis of Late Stage Ovarian Cancer 
The minimum mean misclassification rate is 0.033, with the maximum mean of 
0.044. The minimum value of the sensitivity is 0.911, with a maximum value of 0.931. 
The specificity mean varies between 0.970 and 0.978. The whole result is shown in Table 
22. 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Misclassification 
rate 
0.01 Mean 
(median) 
0.038 
(0.023) 
0.033 
(0.023) 
0.034 
(0.023) 
  Q1  
Q3 
0.023 
0.047 
0.023 
0.047 
0.023 
0.047 
  Min,  
Max 
0.000 
0.140 
0.000 
0.116 
0.000 
0.140 
Sensitivity  Mean 
(median) 
0.925 
(0.929) 
0.929 
(0.920) 
0.931 
(0.929) 
  Q1  
Q3 
0.875 
1.000 
0.881 
1.000 
0.889 
1.000 
  Min  
Max 
0.667 
1.000 
0.667 
1.000 
0.667 
1.000 
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Table 22 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.01 Mean 
(median) 
0.975 
(0.972) 
0.980 
(1.000) 
0.978 
(0.972) 
  Q1  
Q3 
0.967 
1.000 
0.968 
1.000 
0.968 
1.000 
  Min  
Max 
0.879 
1.000 
0.879 
1.000 
0.879 
1.000 
Misclassification 
rate 
0.02 Mean 
(median) 
0.040 
(0.047) 
0.037 
(0.023) 
0.038 
(0.023) 
  Q1  
Q3 
0.023 
0.052 
0.023 
0.047 
0.023 
0.047 
  Min  
Max 
0.000 
0.140 
0.000 
0.116 
0.000 
0.140 
Sensitivity  Mean 
(median) 
0.922 
(0.923) 
0.923 
(0.917) 
0.922 
(0.917) 
  Q1 
Q3 
0.875 
1.000 
0.875 
1.000 
0.875 
1.000 
  Min  
Max 
0.625 
1.000 
0.667 
1.000 
0.667 
1.000 
Specificity  Mean 
(median) 
0.973 
(0.971) 
0.977 
(0.972) 
0.975 
(0.971) 
  Q1  
Q3 
0.966 
1.000 
0.968 
1.000 
0.967 
1.000 
  Min  
Max 
0.871 
1.000 
0.879 
1.000 
0.879 
1.000 
Misclassification 
rate 
0.05 Mean 
(median) 
0.044 
(0.047) 
0.043 
(0.047) 
0.043 
(0.047) 
  Q1  
Q3 
0.023 
0.070 
0.023 
0.070 
0.023 
0.070 
  Min  
Max 
0.000 
0.140 
0.000 
0.140 
0.000 
0.140 
Sensitivity  Mean 
(median) 
0.914 
(0.917) 
0.912 
(0.909) 
0.911 
(0.909) 
  Q1  
Q3 
0.857 
1.000 
0.857 
1.000 
0.857 
1.000 
  Min  
Max 
0.625 
1.000 
0.667 
1.000 
0.667 
1.000 
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Table 22 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.05 Mean 
(median) 
0.970 
(0.971) 
0.972 
(0.971) 
0.972 
(0.971) 
  Q1  
Q3 
0.943 
1.000 
0.963 
1.000 
0.966 
1.000 
  Min  
Max 
0.861 
1.000 
0.879 
1.000 
0.879 
1.000 
Table 22: Classification of the late stage ovarian cancer using classification trees with 
pruning and bagging 
 
3. 5. 3. Classification Tree Analysis of Breast Cancer 
The minimum mean misclassification rate is 0.035, with the maximum mean of 
0.164. The minimum value of the sensitivity is 0.718, with a maximum value of 0.940. 
The specificity mean varies between 0.917 and 0.982. The whole result is shown in Table 
23. 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Misclassification 
rate 
0.01 Mean 
(median) 
0.074 
(0.074) 
0.045 
(0.037) 
0.035 
(0.037) 
  Q1  
Q3 
0.056 
0.093 
0.019 
0.056 
0.019 
0.056 
  Min,  
Max 
0.000 
0.241 
0.000 
0.130 
0.000 
0.093 
Sensitivity  Mean 
(median) 
0.890 
(0.900) 
0.916 
(0.920) 
0.940 
(0.952) 
  Q1  
Q3 
0.848 
0.950 
0.889 
0.953 
0.909 
0.969 
  Min  
Max 
0.696 
1.000 
0.750 
1.000 
0.773 
1.000 
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Table 23 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.01 Mean 
(median) 
0.951 
(0.964) 
0.982 
(1.000) 
0.982 
(1.000) 
  Q1  
Q3 
0.930 
0.974 
0.968 
1.000 
0.969 
1.000 
  Min  
Max 
0.807 
1.000 
0.895 
1.000 
0.897 
1.000 
Misclassification 
rate 
0.02 Mean 
(median) 
0.096 
(0.093) 
0.071 
(0.074) 
0.060 
(0.056) 
  Q1  
Q3 
0.074 
0.130 
0.037 
0.093 
0.037 
0.074 
  Min  
Max 
0.000 
0.278 
0.000 
0.185 
0.000 
0.130 
Sensitivity  Mean 
(median) 
0.846 
(0.857) 
0.866 
(0.872) 
0.891 
(0.900) 
  Q1 
Q3 
0.792 
0.909 
0.817 
0.917 
0.850 
0.944 
  Min  
Max 
0.609 
1.000 
0.655 
1.000 
0.700 
1.000 
Specificity  Mean 
(median) 
0.944 
(0.962) 
0.974 
(0.972) 
0.976 
(0.972) 
  Q1  
Q3 
0.916 
0.971 
0.964 
1.000 
0.966 
1.000 
  Min  
Max 
0.750 
1.000 
0.871 
1.000 
0.889 
1.000 
Misclassification 
rate 
0.05 Mean 
(median) 
0.164 
(0.167) 
0.142 
(0.130) 
0.135 
(0.130) 
  Q1  
Q3 
0.130 
0.204 
0.111 
0.185 
0.111 
0.167 
  Min  
Max 
0.019 
0.315 
0.019 
0.296 
0.019 
0.296 
Sensitivity  Mean 
(median) 
0.721 
(0.725) 
0.718 
(0.720) 
0.732 
(0.739) 
  Q1  
Q3 
0.652 
0.800 
0.667 
0.800 
0.667 
0.800 
  Min  
Max 
0.333 
0.952 
0.455 
0.955 
0.440 
0.955 
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Table 23 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.05 Mean 
(median) 
0.917 
(0.925) 
0.957 
(0.968) 
0.959 
(0.968) 
  Q1  
Q3 
0.882 
0.966 
0.936 
1.000 
0.936 
0.981 
  Min  
Max 
0.733 
1.000 
0.793 
1.000 
0.833 
1.000 
Table 23: Classification of the breast cancer using classification trees with pruning and 
bagging 
 
3. 5. 4. Classification Tree Analysis of Endometrial Cancer 
The minimum mean misclassification rate is 0.044, with the maximum mean of 
0.077. The minimum value of the sensitivity is 0.908, with a maximum value of 0.929. 
The specificity mean varies between 0.930 and 0.969. The whole result is shown in Table 
24. 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Misclassification 
rate 
0.01 Mean 
(median) 
0.049 
(0.041) 
0.046 
(0.041) 
0.044 
(0.041) 
  Q1  
Q3 
0.020 
0.061 
0.020 
0.061 
0.020 
0.061 
  Min,  
Max 
0.000 
0.184 
0.000 
0.184 
0.000 
0.143 
Sensitivity  Mean 
(median) 
0.929 
(0.941) 
0.927 
(0.941) 
0.929 
(0.941) 
  Q1  
Q3 
0.888 
1.000 
0.882 
1.000 
0.887 
1.000 
  Min  
Max 
0.688 
1.000 
0.706 
1.000 
0.714 
1.000 
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Table 24 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.01 Mean 
(median) 
0.962 
(0.968) 
0.968 
(0.970) 
0.969 
(0.971) 
  Q1  
Q3 
0.939 
1.000 
0.943 
1.000 
0.948 
1.000 
  Min  
Max 
0.839 
1.000 
0.871 
1.000 
0.871 
1.000 
Misclassification 
rate 
0.02 Mean 
(median) 
0.055 
(0.061) 
0.053 
(0.041) 
0.052 
(0.041) 
  Q1  
Q3 
0.020 
0.082 
0.020 
0.082 
0.020 
0.066 
  Min  
Max 
0.000 
0.184 
0.000 
0.184 
0.000 
0.163 
Sensitivity  Mean 
(median) 
0.914 
(0.933) 
0.911 
(0.926) 
0.912 
(0.923) 
  Q1 
Q3 
0.875 
0.952 
0.875 
0.952 
0.875 
0.952 
  Min  
Max 
0.688 
1.000 
0.684 
1.000 
0.684 
1.000 
Specificity  Mean 
(median) 
0.961 
(0.969) 
0.966 
(0.970) 
0.966 
(0.970) 
  Q1  
Q3 
0.939 
1.000 
0.941 
1.000 
0.943 
1.000 
  Min  
Max 
0.865 
1.000 
0.861 
1.000 
0.861 
1.000 
Misclassification 
rate 
0.05 Mean 
(median) 
0.077 
(0.082) 
0.077 
(0.082) 
0.077 
(0.082) 
  Q1  
Q3 
0.056 
0.102 
0.061 
0.102 
0.061 
0.102 
  Min  
Max 
0.000 
0.224 
0.000 
0.224 
0.000 
0.224 
Sensitivity  Mean 
(median) 
0.910 
(0.929) 
0.909 
(0.923) 
0.908 
(0.923) 
  Q1  
Q3 
0.867 
0.951 
0.867  
0.951 
0.867 
0.950 
  Min  
Max 
0.632 
1.000 
0.632 
1.000 
0.632 
1.000 
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Table 24 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.05 Mean 
(median) 
0.930 
(0.933) 
0.930 
(0.933) 
0.930 
(0.933) 
  Q1  
Q3 
0.903 
0.967 
0.903 
0.967 
0.903 
0.967 
  Min  
Max 
0.807 
1.000 
0.807 
1.000 
0.807 
1.000 
Table 24: Classification of the endometrial cancer using classification trees with pruning 
and bagging 
 
3. 5. 5. Classification Tree Analysis of Lung Cancer 
The minimum mean misclassification rate is 0.054, with the maximum mean of 
0.076. The minimum value of the sensitivity is 0.695, with a maximum value of 0.788. 
The specificity mean varies between 0.977 and 0.985. The whole result is shown in Table 
25. 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Misclassification 
rate 
0.01 Mean 
(median) 
0.062 
(0.050) 
0.056 
(0.050) 
0.054 
(0.050) 
  Q1  
Q3 
0.025 
0.075 
0.025 
0.075 
0.025 
0.075 
  Min,  
Max 
0.000 
0.175 
0.000 
0.175 
0.000 
0.175 
Sensitivity  Mean 
(median) 
0.770 
(0.800) 
0.774 
(0.800) 
0.788 
(0.800) 
  Q1  
Q3 
0.656 
0.889 
0.667 
0.875 
0.714 
0.889 
  Min  
Max 
0.286 
1.000 
0.286 
1.000 
0.286 
1.000 
 
 
 55
Table 25 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.01 Mean 
(median) 
0.977 
(0.971) 
0.984 
(1.000) 
0.984 
(1.000) 
  Q1  
Q3 
0.968 
1.000 
0.970 
1.000 
0.970 
1.000 
  Min  
Max 
0.906 
1.000 
0.914 
1.000 
0.900 
1.000 
Misclassification 
rate 
0.02 Mean 
(median) 
0.064 
(0.050) 
0.062 
(0.050) 
0.061 
(0.050) 
  Q1  
Q3 
0.025 
0.100 
0.025 
0.100 
0.025 
0.081 
  Min  
Max 
0.000 
0.175 
0.000 
0.175 
0.000 
0.175 
Sensitivity  Mean 
(median) 
0.755 
(0.778) 
0.733 
(0.750) 
0.749 
(0.774) 
  Q1 
Q3 
0.661 
0.875 
0.600 
0.857 
0.667 
0.857 
  Min  
Max 
0.286 
1.000 
0.286 
1.000 
0.286 
1.000 
Specificity  Mean 
(median) 
0.979 
(1.000) 
0.985 
(1.000) 
0.984 
(1.000)  
  Q1  
Q3 
0.968 
1.000 
0.970 
1.000 
0.970 
1.000 
  Min  
Max 
0.914 
1.000 
0.914 
1.000 
0.917 
1.000 
Misclassification 
rate 
0.05 Mean 
(median) 
0.0763 
(0.0750) 
0.072 
(0.0750) 
0.072 
(0.075)  
  Q1  
Q3 
0.050 
0.100 
0.050 
0.100 
0.050 
0.100 
  Min  
Max 
0.000 
0.225 
0.000 
0.200 
0.000 
0.175 
Sensitivity  Mean 
(median) 
0.698 
(0.714) 
0.697 
(0.707) 
0.701 
(0.714) 
  Q1  
Q3 
0.600 
0.800 
0.600 
0.800 
0.600 
0.800 
  Min  
Max 
0.250 
1.000 
0.250 
1.000 
0.250 
1.000 
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Table 25 continued 
Bootstrap samples Index Complexity 
Parameter 
Statistical 
Summary 5 20 50 
Specificity 0.05 Mean 
(median) 
0.977 
(0.971) 
0.982 
(1.000) 
0.981 
(1.000) 
  Q1  
Q3 
0.967 
1.000 
0.969 
1.000 
0.970 
1.000 
  Min  
Max 
0.893 
1.000 
0.903 
1.000 
0.914 
1.000 
Table 25: Classification of the lung cancer using classification trees with pruning and 
bagging 
 
4. Discussion 
Because of the multifactorial nature of cancer, it is very likely that a combination 
of several markers will be necessary to detect and diagnose cancer effectively. In addition, 
cancer screening in general requires a strategy with high sensitivity (>75%) and 
specificity (>99.6%) to achieve a high positive predictive value to detect its early 
stage.[24] This study demonstrates the diagnostic utility of the cytokine panel by using a 
novel multianalyte LabMAP profiling technology and the statistical analysis of the 
classification tree model for predicting cancer status. We used 28 biomarkers, collected 
cross-sectionally, from controls and patients with four types of cancers, ovarian, breast, 
endometrial and lung cancer, in comparison with normal controls. Different variations of 
classification trees were applied to data on these four types of cancers in an effort to 
explore which variations produced the highest classification. As a comparison, logistic 
regression with the forward stepwise regression was utilized as a standard method.   
The first analysis presented here focused on ovarian cancer. During the past few 
decades, many studies have been done in this field. More than 30 serum markers have 
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been evaluated alone and in combination with CA-125.[5,24] Recent candidates include: 
HE4, mesothelin, M-CSF, osteopontin, kallikrein(s) and soluble EGF receptor.[24] A 
variety of statistical methods are being utilized to analyze combinations of markers to 
improve the sensitivity and specificity.[24] ROC curves from these methods have 
produced sensitivities between 90% and 100% with specificities of 70% to 80%.[5] In 
this thesis, average sensitivities of 93% with average specificities of 98% were achieved. 
The second set of analyses focused on breast cancer. Recently, a number of 
different methods have been implemented for breast cancer detection. For instance, 
immunoassay panels use tissue-specific cancer biomarkers and multiphoton-detection 
(IA/MPD) to allow for the measurement of cancer biomarkers with very low 
concentrations in the blood.[25] Other methods being used to identify biomarkers include 
MicroRNA expression profiling [26], and lysates prepared from large core needle 
biopsies, which are then analyzed (with bead-based miniaturized sandwich immunoassays 
specific) for 54 preselected proteins.[27] 
The last two cancers analyzed here were endometrial and lung cancers. Methods to 
detect endometrial cancer include a panel of serum biomarkers and multiplex xMAP™ 
bead-based immunoassay. These methods were used in conjunction with the 
classification trees, logistic regression, separating hyperplanes [28], and k nearest 
neighbors [29, 30]. For lung cancer, technical developments in bronchoscopic techniques 
have led to detection of a new morphological entity (angiogenic squamous dysplasia), 
which might be an important biomarker and target for antiangiogenic chemopreventive 
agents.[31] 
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In this thesis, the results showed very high sensitivity and specificity with 
classification tree models. For ovarian cancer, we obtained the sensitivity of 93% and the 
specificity of 98%. Other research groups have achieved 84% sensitivity with 95% 
specificity,[5] and 81% sensitivity with 99% specificity.[32] For endometrial cancer, 
findings showed a sensitivity of 93% and specificity of 97%, which although very high, 
are slightly lower than the 98.3% sensitivity and 98% specificity achieved by another 
group that identified prolactin as the strongest discriminative biomarker for endometrial 
cancer.[31] For lung cancer, a 79% sensitivity and 98% specificity were obtained, which 
was far superior to other studies which utilized hnRNP A2/B1 overexpression in sputum 
epithelium cells to achieve 74% sensitivity and 70% specificity.[33] 
These results demonstrated that classification trees led to the maximum mean 
sensitivity of 94% and the specificity of 98%. Logistic regression led to the maximum 
mean sensitivity of 86% and the specificity of 95%. For each cancer, in general, better 
results were obtained from the classification tree model than that from logistic regression 
with the forward stepwise selection. Although this result is not surprising, given the 
greater flexibility of the tree model, it does help to demonstrate that non-parametric tree 
models can often achieve the superior classification as compared to standard techniques. 
For the classification tree approach, variations in both the number of bootstrap 
samples (for bagging), and the complexity parameter (for pruning) were explored. Using 
5, 20 and 50 bootstrap samples led to improved average prediction as compared to the 
trees without bagging. On the other hand, using a complexity parameter of 0.01, 0.02, and 
0.05 typically led to similar or worse results. For a complexity parameter of 0.01, results 
were the same as those without pruning. Further increases in the degree of pruning, 
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however, sometimes led to worse classification. This is likely due to resulting models 
which are overly simple for the underlying problem. As an example of this result, the 
classification with lung cancer was lower with a higher complexity parameter, but for 
endometrial cancer a complexity parameter of 0.02 improved the classification. Although 
it would be useful to associate the values of the complexity parameter with a specific 
number of variables, or specific number of terminal nodes, there is currently no way to 
accomplish this in general. Future research will investigate this issue further. 
In addition to comparing the classification tree with logistic regression for these 
four cancer types, for each cancer, the best result came from one method, the 
classification trees with bagging. For early stage ovarian cancer and breast cancer, the 
best result in this research came from the classification tree model with bagging. The 
worst models were from the classification trees without bagging or pruning. For this case, 
logistic regression with the forward stepwise selection can be applied for the analysis. 
Meanwhile, the classification trees with bagging affected the case of breast cancer most. 
Compared with the result from the classification tree without pruning or bagging, for 
breast cancer, the misclassification rate decreased 20%, the sensitivity increased 24%, 
and the specificity increased 18% when we used the classification tree model with 
bagging. However, for late stage ovarian cancer, compared with logistic regression, there 
was only 1% increase of the specificity from the classification trees with bagging.  
Although results seemed very promising, there were potential limitations. First, 
optimistically biased results cannot be completely avoided from using the cross-
validation. Although cross-validation can reduce the classification bias by using different 
observations for the training and test data sets,[17,18] the same observations from the 
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given data set were still used multiple times in predicting case status. The gold standard is 
to use an independent validation set of completely different subjects which are 
independent from those used to train the model.[17] Unfortunately such a data set is not 
currently available within the context of this specific study. 
In addition, these data were assembled from a variety of investigators at the 
University of Pittsburgh Cancer Institute (UPCI) and other universities collaborating with 
UPCI. Although there is no specific reason to believe the data set has any specific biases, 
the patients represent a mix of subjects enrolled through a variety of collaborative efforts. 
It is therefore unlikely that we can associate this sample data with any particular 
underlying population. It is also then unclear how well this sample would generalize to a 
new sample from a more general or a different population. 
Finally, although the bootstrap approach gave better results, it does not retain the 
straightforward clinical interpretation of the individual tree models. If we are going to use 
aggregate trees from bagging, we should have some other methods, such as a nomogram 
which was invented by the French mathematicians Massau and M. P. Ocagne in 1889. 
Nomogram is a set of scales that will solve a specific equation. Given all but one of the 
values for the equation, it will solve for the unknown value.[36] We use this method to 
map covariate values to predicted probabilities and subsequent classification. Creating a 
tool such as a nomogram, however, is not straightforward, and involves many steps such 
as reducing the number of markers and validating results. 
In general, our main objective was simply to examine results from different 
variations of classification trees for these specific data. The utilized statistical methods 
were found to be useful in past studies of similar data[5,34,35] and easily interpretable 
 61
for future applications in clinical practice. We did not investigate other classification 
methods such as neural networks and clustering. Neural networks are tools of non-linear 
statistical data modeling. They can be used to model complex relationships between 
predicting variables and response variables. Their output values can enhance 
classification; some applications of such methods have shown good generalization with 
classification of multiple images.[36,37]  
Clustering should also be evaluated in future analyses of these data. Clustering is a 
non-linear unsupervised method. The clustering algorithm divides the data set into 
clusters whose members share certain properties; ideally those clusters can then used to 
predict case status.[38,39] Any of those methods may provide better classification than 
classification trees, although tree models are more easily interpretable. Future studies can 
investigate other such methods. 
The given technology shows great promise as a good tool for cancer detection. In 
this thesis, data from the described laboratory and statistical approaches were applied to a 
large sample of patients. The clinical applicability of the Luminex panel and biomarkers 
is apparent, and the accuracy of the detection of early stage cancer is improved with the 
classification trees. 
 
5. Conclusion 
The analysis of multiple serum cytokines using a novel LabMAP technology is a 
promising approach for the development of a diagnostic assay for ovarian, breast, 
endometrial, and lung cancer. Meanwhile, with the classification trees, accuracy of early 
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stage detection is enhanced. The ROC curves show significantly high sensitivities and 
specificities. 
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